Hainan Poly Pharm Co Ltd Cash Flow Conversion Efficiency

Latest as of June 2023: 0.015x

Hainan Poly Pharm Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Hainan Poly Pharm Co Ltd (300630) has a cash flow conversion efficiency ratio of 0.015x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥44.82 Million ≈ $6.56 Million USD) by net assets (CN¥3.01 Billion ≈ $440.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Hainan Poly Pharm Co Ltd stock valuation for the company's overall valuation and market capitalisation.

Cash Flow Conversion Efficiency of Hainan Poly Pharm Co Ltd (2016–2023)

Cash flow conversion efficiency of Hainan Poly Pharm Co Ltd from 2016 to 2023. This chart illustrates how Hainan Poly Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Hainan Poly Pharm Co Ltd stock quote for real-time trading data and today's change.

Hainan Poly Pharm Co Ltd Cash Flow Conversion Ratio Explained

Hainan Poly Pharm Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Hainan Poly Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hainan Poly Pharm Co Ltd ranked by their cash flow conversion efficiency. Review 300630 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Company	Cash Flow Conversion Efficiency
Xtra-Gold Resources Corp TO:XTG	0.081x
Alithya Group inc Class A TO:ALYA	-0.034x
Tridomain Performance Materials PT JK:TDPM	0.076x
Charoong Thai Wire and Cable Public Company Limited BK:CTW	-0.004x
AEC SECURITIES BK:BYD-R	N/A
XAC Automation TWO:5490	0.082x
INITECH Co. Ltd KQ:053350	-0.003x
Afarak Group Oyj HE:AFAGR	0.001x

Annual Cash Flow Conversion Efficiency for Hainan Poly Pharm Co Ltd (2016–2023)

The table below shows the annual cash flow conversion efficiency of Hainan Poly Pharm Co Ltd from 2016 to 2023. Also see total assets of Hainan Poly Pharm Co Ltd for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2023-12-31	CN¥2.91 Billion ≈ $425.27 Million	CN¥112.72 Million ≈ $16.49 Million	0.039x	-79.66%
2022-12-31	CN¥2.80 Billion ≈ $410.10 Million	CN¥534.29 Million ≈ $78.18 Million	0.191x	+208.59%
2021-12-31	CN¥2.54 Billion ≈ $371.94 Million	CN¥157.03 Million ≈ $22.98 Million	0.062x	-62.06%
2020-12-31	CN¥2.04 Billion ≈ $298.39 Million	CN¥332.08 Million ≈ $48.59 Million	0.163x	-13.35%
2019-12-31	CN¥1.15 Billion ≈ $167.69 Million	CN¥215.37 Million ≈ $31.52 Million	0.188x	+75.14%
2018-12-31	CN¥883.26 Million ≈ $129.25 Million	CN¥94.79 Million ≈ $13.87 Million	0.107x	-17.46%
2017-12-31	CN¥721.37 Million ≈ $105.56 Million	CN¥93.79 Million ≈ $13.72 Million	0.130x	-28.09%
2016-12-31	CN¥307.12 Million ≈ $44.94 Million	CN¥55.53 Million ≈ $8.13 Million	0.181x	--

About Hainan Poly Pharm Co Ltd

SHE:300630 China Drug Manufacturers - Specialty & Generic

Market Cap

$73.10 Million

CN¥499.57 Million CNY

Market Cap Rank

#20315 Global

#4677 in China

Share Price

CN¥0.89

Change (1 day)

+0.00%

52-Week Range

CN¥0.89 - CN¥0.89

All Time High

CN¥70.54